ITPS Canada Achieves NATO Flight Training Europe Accreditation 
Toronto Stock Exchange, TSX Venture Exchange, TSX Alpha Exchange and Montreal Exchange Closed for Labour Day 
Doubleview Appoints Edward Huebert as Vice President, Permitting, Regulatory & Indigenous Relations 
Focus Graphite and C4V to Evaluate Mine-to-Anode Platform Combining Lac Knife Graphite with C4V’s Green Anode Technology 
Spritzer Sparkling Invites Malaysians to ‘Reset Rasa’ This Merdeka, Rediscover the Flavours That Unite Us INNIO Group to Acquire Northeast-Western Energy Systems (NES-WES) – Largest Distributor for Jenbacher Solutions in the U.S.
JENBACH, AUSTRIA / ACN Newswire / September 25, 2023 / The INNIO Group (INNIO*) today…
New Campaign from Arcutis Aims to Educate, Raise Awareness, and Provide Encouragement for Those Living with Seborrheic Dermatitis
WESTLAKE VILLAGE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), an…
New Campaign from Arcutis Aims to Educate, Raise Awareness, and Provide Encouragement for Those Living with Seborrheic Dermatitis
WESTLAKE VILLAGE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) — Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), an…
Scilex Holding Company announces the State of Indiana Medicaid will add Elyxyb as a preferred agent to its preferred drug list (PDL) effective October 1, 2023
PALO ALTO, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”…
Scilex Holding Company announces the State of Indiana Medicaid will add Elyxyb as a preferred agent to its preferred drug list (PDL) effective October 1, 2023
PALO ALTO, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) — Scilex Holding Company (Nasdaq: SCLX, “Scilex”…
Editas Medicine Strengthens Executive Leadership Team with Appointment of Caren Deardorf as Chief Commercial and Strategy Officer
Caren Deardorf Editas Medicine, today announced the appointment of Caren Deardorf as the Company’s first…
Editas Medicine Strengthens Executive Leadership Team with Appointment of Caren Deardorf as Chief Commercial and Strategy Officer
Caren Deardorf Editas Medicine, today announced the appointment of Caren Deardorf as the Company’s first…
PharmAla Receives First Office Action for PharmAla-1 PCT Filing
PCT Examiner Finds Molecule to be both Novel and Inventive VANCOUVER, British Columbia, Sept. 25,…
PharmAla Receives First Office Action for PharmAla-1 PCT Filing
PCT Examiner Finds Molecule to be both Novel and Inventive VANCOUVER, British Columbia, Sept. 25,…
Regeneron Completes Acquisition of Decibel Therapeutics, Adding Promising Gene Therapy Programs for Hearing Loss
TARRYTOWN, N.Y., Sept. 25, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced…
Regeneron Completes Acquisition of Decibel Therapeutics, Adding Promising Gene Therapy Programs for Hearing Loss
TARRYTOWN, N.Y., Sept. 25, 2023 (GLOBE NEWSWIRE) — Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced…
Celldex Therapeutics to Present at Cantor Global Healthcare Conference
HAMPTON, N.J., Sept. 25, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that…
Celldex Therapeutics to Present at Cantor Global Healthcare Conference
HAMPTON, N.J., Sept. 25, 2023 (GLOBE NEWSWIRE) — Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced today that…
Wave Life Sciences to Present at the Chardan 7th Annual Genetic Medicines Conference
CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
Wave Life Sciences to Present at the Chardan 7th Annual Genetic Medicines Conference
CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) — Wave Life Sciences Ltd. (Nasdaq: WVE), a…
TransCode Therapeutics Announces Positive Pre-Clinical Glioblastoma Results with Lead Therapeutic Candidate, TTX-MC138
Further Supports TTX-MC138 Application in Brain Cancer BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) — TransCode…
TransCode Therapeutics Announces Positive Pre-Clinical Glioblastoma Results with Lead Therapeutic Candidate, TTX-MC138
Further Supports TTX-MC138 Application in Brain Cancer BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) — TransCode…
FDA Issues Complete Response Letter (CRL) for UDENYCA® ONBODY™ Biologics License Application Solely Due to an Ongoing Review of Inspection Findings at a Third-Party Filler; Coherus Also Announces Completion of Toripalimab FDA Inspections
– No issues with clinical efficacy or safety, trial design, labeling, drug substance manufacturing, or…
FDA Issues Complete Response Letter (CRL) for UDENYCA® ONBODY™ Biologics License Application Solely Due to an Ongoing Review of Inspection Findings at a Third-Party Filler; Coherus Also Announces Completion of Toripalimab FDA Inspections
– No issues with clinical efficacy or safety, trial design, labeling, drug substance manufacturing, or…
Valo Health and Novo Nordisk to collaborate to discover and develop novel treatments for cardiometabolic diseases using human data and artificial intelligence
Collaboration will apply Valo’s Opal Computational Platform™ and real-world patient dataset to enable the discovery…